Check out our new publication looking at what clinicians, pharmacists, and patients really want from AI-assisted tools to support medication reviews. www.jmir.org/2026/1/e74304

Meet Dr Maurice O'Connell @mauriceoconnell.bsky.social, research associate in statistics @manchester.ac.uk. Maurice bring deep expertise in causal inference, machine learning, counterfactual prediction and decision theory to DynAIRx - helping us understand what works, for whom, and why. #Statistics

Just back from #ISCB46, where @mauriceoconnell.bsky.social shared insights on modelling complex treatment effects in clinical data. Here’s how his work is pushing boundaries in biostatistics 👇

Had an amazing time at #ISCB46 in Basel, Switzerland! Got to present my work on causal inference and polypharmacy research @officialuom.bsky.social @dynairx.bsky.social , connect with the international stats community @ISCB_info, and explore the city with my family.

Maurice did a brilliant job presenting #DynAIRx causal inference work at #ICoSDS2025. Great to hear questions on using dynamic treatment strategy censoring to achieve positivity in IP censor weighting with EHR data—right at the heart of the challenge! 💊 #CausalInference @mauriceoconnell.bsky.social

Proud to see our brilliant ECR @mauriceoconnell.bsky.social present his causal inference work from the #DynAIRx project at #ICoSDS2025 in Vancouver. Great to see his research sparking interest in the stats/data science community. A big milestone! 📊💊 #CausalInference #EarlyCareerResearcher

Grateful to present recent research @SFU International Conference in Statistics & Data Science 2025 Simon Fraser University in Vancouver on #TargetTrialEmulation using electronic health records to estimate average treatment effects & #CausalML conditional average treatment effects

“An automation framework for clinical codelist development validated with UK data from patients with multiple long-term conditions.” #polypharmacy #multimorbidity #ElectronicHealthRecords ‪@dynairx.bsky.social doi.org/10.1186/s128...

Great to see the DynAIRx ECRs presenting their work at the Multiple Long-Term Conditions: From Research to Reality End of Programme Showcase. @mykelismyname.bsky.social @mauriceoconnell.bsky.social @asraaslam.bsky.social #ECRs #Research

You can view the recording of my online talk at Turing Institute here on YouTube on #causalinference #TargetTrial emulation #CausalMachineLearning #polypharmacy & #deprescribing on research with @mattsperrin.bsky.social @dynairx.bsky.social @uniofmanchester.bsky.social youtu.be/z0CtfYnu3b8?...